Overview

Efficacy of Faviprevir in COVID-19 Treatment

Status:
Completed
Trial end date:
2020-09-28
Target enrollment:
Participant gender:
Summary
Faviprevir in COVID-19 treatment
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Tanta University
Treatments:
Chloroquine
Favipiravir